Related Content
Download content relating to this event and topic.
Biologics Manufacturing Germany 2025
Germany's Premier Gathering for The Biopharma Comminuty
Biologics Manufacturing Germany 2025 unites industry leaders to explore innovations and challenges in Europe's fourth-largest biopharma manufacturing sector.
200
+
Attendees
100
+
Companies
30
+
Speakers
20
+
Networking Hours
8
+
Case Studies
About the Event
Germany's biopharmaceutical sector ranks fourth globally with 650+ biotech companies, driven by strong industry-research-government collaboration and bioregions. The sector experiences 8% annual prescription growth due to increasing chronic diseases and an aging population, with companies like Calidi Biotherapeutics, Eleva Biologics, and Roche benefiting from Germany's strategic advantages. The Biologics Manufacturing Germany 2025 conference will address these developments, featuring industry leaders like Uwe Gottschalk and representatives from Sanofi, Abbvie, and Roche, while offering 120+ networking opportunities, an awards ceremony, and expert sessions on bioprocessing, CMC strategy, and facility design, focusing on critical issues such as risk mitigation, regulatory compliance, automation, AI, and sustainability in the evolving biologics manufacturing landscape.
.avif)
Speakers
Esteemed Voices From the Industry
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Vitaly Biniyaminov
Automation Expert
Steinbeis-Beratungszentrum Digitale Transformation und Prozessautomatisierung
Germany
Stephen Sullivan
COO
iPSirius
United Kingdom
Ralf Huss
Managing Director
Biom Biotech Cluster
Germany
Paul Matejtschuk
Head Formulation Science
Medicines & Healthcare Products Regulatory Agency
United Kingdom
Mohamed Noor
Digitalization Manager - Biopharma 4.0
NIBRT National Institute for Bioprocessing Research and Training
Ireland
John Manneke
Senior Procurement Manager/ Global Category Manager DS
Roche
Switzerland
Jan Talts
COO
Amniotics
Sweden
Ingo Gorr
Head of Therapeutic Virus Development
Boehringer Ingelheim
Germany
Harald Bradl
Director & Head of Downstream Development
Boehringer Ingelheim
Germany
Filippo Ramondelli
Associate Director CMC Lead
Takeda
Italy
Elizabeth Oladipo
Quality Assurance Specialist
Abbott
Ireland
Dr. Pavan Narayanaswamy
Head of CMC and Regulatory Affairs
AATec Medical
Germany
Registration
Choose a plan that fits your role, company and industry.
BIG PHARMA
£2450 (+VAT)*
*STANDRAD RATE
Valid until 7 February 2025
FINAL CALL: £2650 (+VAT)
From 08 February 2025 - 16 February 2025
Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
BIOPHARMA & ACADEMIC
£1350 (+VAT)*
*STANDRD RATE
Valid until 7 February 2025
FINAL CALL: £1550 (+VAT)From 08 February 2025 - 16 February 2025
Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
TECH/ SERVICE/ SOLUTION PROVIDERS
Attendance Only
Representatives of service, solution, and technology providers are welcome to attend Biologics Manufacturing Germany 2025.
Get in touch and download the prospectus for detailed information on attendance options, sponsorship opportunities and benefits, and how to maximise your presence at #BMG2025.
Want to Speak at This Event?
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Agenda at a Glance
View the agenda for
Biologics Manufacturing Germany 2025
Biomanufacturing in Focus: Advancing Efficiency, Collaboration, and Leadership in Germany
- Keynote Address: Building a Biomanufacturing Powerhouse: Synergies and Opportunities in Germany
- Turning Setbacks into Success: Conducting Effective Investigations in Manufacturing
- Turning Setbacks into Success: Conducting Effective Investigations in Manufacturing
- Panel: Biopharma Optimization Showdown: Intensify or Go Continuous?
Advances in Upstream Processing and Cell-Line Development
- Utilizing automation and AI to maintain optimal conditions for high-density culture
- Advanced High-Throughput Screening Solutions for Streamlined Upstream Processing
- High-Throughput Screening Strategies for Streamlined Cell Line Development
Downstream Processing Optimization
- Reducing Downstream Scale-Up Needs: Advances Toward Continuous Downstream Processing (CDSP)
- Enhancing Downstream Processing with Continuous Downstream Processing (CDSP) Solutions
- Tackling the challenges of antibody-drug conjugate (ADC) manufacturing: innovative purification techniques and process simplification strategies.
Optimizing Biopharmaceutical Quality: QbD, GMP, and Issue Resolution
- QbD: Architecting a Robust Manufacturing Future for Biopharmaceuticals
- GMP Requirements for Cell and Gene Therapy Manufacturing
- Effective CGT Issue Resolution: Root Cause Analysis and CAPA Management
- Case Study: Xbrane and the development of high quality Biosimilars
10 Round Table
- AI and Lab Automation for Biomanufacturing
- Addressing the Biopharma Talent Shortage
- Understanding Genome Editing for Cell-Line Development
- Optimizing Biomanufacturing Processes with Industry 5.0 Innovations
- Platform Optimization for Efficient AAV Purification
- Key Aspects of Contamination Control Strategy in Vaccine and Biologics Production
- Current and Emerging Technologies to Optimize mRNA Manufacturing
- Enhancing Lyophilization Cycle Times and Stability for Complex Injectable Drugs
10 Round Table
- Industrial IoT (IIoT) Platforms for Decentralized Production and Smart Factories
- Industrial Platforms for Decentralized Production and Smart Factories
- Role of Data analytics towards Industry 4.0
Facility Design & CMC Strategies
- Integrate facility design and CMC considerations into the Biopharma Optimization Showdown.
- Key Ingredients for a Powerful CMC Strategy
- Panel: Key Ingredients for a Powerful CMC Strategy
Advanced Strategies in Tech-Transfer: Cost Management and Sustainable Practices
- Strategies to Mitigate Early Adoption Costs of GMP-Grade Materials
- Sustainable Strategies for Streamlining Tech-Transfer Processes in Biomanufacturing
- Examining sustainability in CMO selection: How to integrate it without compromising quality and cost competitiveness?
New Drug Modalities
- Manufacturing of Novel off-the-shelf allogeneic Virotherapies
- Panel: Manufacturing and Commercialization Process / Cost Optimization
Ready to attend?
Register today to get limited super access and save big.
Platinum Sponsors
No items found.
Gold Sponsors
No items found.
Silver Sponsors
No items found.
Bronze Sponsors
Associate Sponsors
No items found.
Exhibitors
Advertisers
No items found.
Want to Sponsor This Event?
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Frequently Asked Questions
How can I stay updated on event details and announcements?
To stay informed about event updates, including date, venue, and agenda, please subscribe to our newsletter on our event website. You can also follow our official social media channels for real-time updates and announcements.
What can I expect to learn and explore during the event?
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
What safety measures will be in place to ensure the safety of attendees?
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Is there a cancellation or refund policy if I can't attend after registering?
Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.
Can I submit a presentation to be a speaker at this event?
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
What type of professionals benefit most from attending?
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
What advantages does this conference offer participants?
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Are there networking opportunities or special events planned?
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Are there sponsorship opportunities for this event?
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
How can I register for the event?
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Be a Part of This Event!
Don't miss out on unique networking, speaking and sponsorship opportunities.